Campbell & CO Investment Adviser LLC Glaukos Corp Transaction History

Campbell & CO Investment Adviser LLC

  • $1.3 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
BUY
$59.53 - $85.11 $1.27 Million - $1.82 Million
21,353 New
21,353 $1.7 Million
Q2 2023

Aug 11, 2023
BUY
$45.44 - $71.21 $236,242 - $370,220
5,199 New
5,199 $370,000
Q4 2021

Feb 10, 2022
SELL
$40.27 - $56.99 $797,346 - $1.13 Million
-19,800 Closed
0 $0
Q3 2021

Nov 10, 2021
BUY
$47.43 - $84.23 $939,114 - $1.67 Million
19,800 New
19,800 $954,000

Others Institutions Holding GKOS

# of Institutions
342
Shares Held
46.8M
Call Options Held
132K
Put Options Held
188K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.45B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Campbell & CO Investment Adviser LLC Portfolio

Follow Campbell & CO Investment Adviser LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

News

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email